AKBA - Akebia Therapeutics, Inc.
IEX Last Trade
1.955
0.015 0.767%
Share volume: 67,767
Last Updated: Fri 27 Dec 2024 08:29:43 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.94
0.02
0.77%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2023-03-31 | 2022-12-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q1 2023 | Q4 2022 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-04 | 2022-11-03 | 2023-05-08 | 2023-08-28 | 2023-08-28 | 2023-11-08 | 2024-03-14 | 2024-05-09 | |
Cash flow financing | -9.000 K | -32.937 M | -15.966 M | -1.000 K | -8.000 M | 50.000 K | -1.290 M | 18.475 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -30.660 M | 33.805 M | -17.538 M | -54.679 M | 3.629 M | -7.167 M | -2.308 M | -19.432 M | |
Net income | 29.276 M | -51.865 M | -26.217 M | -9.216 M | -11.172 M | -14.489 M | -47.000 K | -17.985 M | |
Depreciation | 9.426 M | 9.424 M | 9.409 M | 9.419 M | 9.407 M | 9.407 M | 9.404 M | 9.375 M | |
Changes in inventories | 36.272 M | 40.039 M | 20.604 M | 21.568 M | 20.905 M | 18.442 M | 15.691 M | 25.532 M | |
Changes in receivables | 81.869 M | 23.094 M | 17.781 M | 40.284 M | 19.572 M | 22.592 M | 39.290 M | 26.620 M | |
Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net Borrowings | -56.131 M | -77.749 M | -4.620 M | -28.291 M | -23.244 M | -14.968 M | -19.538 M | -23.011 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash Change | 143.893 M | 144.761 M | 56.953 M | 90.466 M | 53.572 M | 46.529 M | 42.925 M | 41.961 M |